세계의 키토산 유도체 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for Chitosan Derivatives was estimated to be worth US$ 51.8 million in 2024 and is forecast to a readjusted size of US$ 78.5 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Chitosan Derivatives cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Chitosan Derivatives are a class of functional materials obtained from natural polysaccharide chitosan through various chemical modifications (e.g., carboxymethylation, quaternization, hydroxypropylation, phosphorylation, acylation, sulfation) or physical processes. These modifications significantly improve chitosan's water solubility, biocompatibility, mechanical strength, film-forming ability, and impart specific biological activities such as antibacterial, antioxidant, anti-tumor, and lipid-lowering properties. They are widely used in biomedical, food, cosmetic, agricultural, etc.

The chitosan derivatives market is advancing toward high value-added and high-tech applications. Growing demand for green biodegradable materials, and expansion in pharmaceuticals and functional consumer products are the main driving forces. Companies must upgrade technology, comply with international standards, and innovate in market promotion to break the low-end capacity bottleneck and capture the global high-end market.

Market Status:

Continuous Demand Growth:

Increasing demand in five major sectors: pharmaceuticals, food, cosmetics, agriculture, and environmental protection, with remarkable growth in biomedicine and sustainable agriculture.

Expanded Product Applications:

Mature markets for carboxymethyl chitosan (CMC-CS), quaternized chitosan (QA-CS), and chitooligosaccharides (COS);

New functional chitosan (e.g., nano drug carriers, smart responsive materials) entering pilot industrialization.

Regional Concentration:

Asia (especially China) is the largest global supplier of raw materials and basic products;

Europe and North America focus on high-end medical and cosmetic products;

South America and Africa emerging in environmental and agricultural applications with large market potential.

Industrial Chain Features:

Transition from low-end crude chitosan to high-purity, high-functionality derivatives;

High-end applications (e.g., gene delivery) still face patent and technological barriers.

Market Prospects:

Global trend towards green materials greatly increases demand for biodegradable and biocompatible substances;

Pharmaceutical & healthcare field: Advanced applications such as drug delivery systems, gene carriers, and tissue engineering present new growth opportunities;

Food & cosmetics field: Expanding demand for natural, safe, functional new products (antibacterial, antioxidant, UV-protective, etc.);

Agricultural field: Rising demand for eco-friendly pesticide/fertilizer carriers and plant resistance enhancers;

Environmental field: Rapid growth in applications such as heavy metal ion adsorption, oil-water separation membranes, and dye decolorization materials.

Market Challenges:

High dependence on advanced technology: Pharmaceutical-grade, nano-grade, and highly functional products still rely on imported core technologies or patent licensing;

Unstandardized international regulations: Inconsistent testing and certification standards for pharmaceutical and food-grade chitosan derivatives across countries cause export barriers;

Excess capacity in low-end products: Severe price competition and product homogenization squeeze profits in the industrial-grade chitosan market;

Seasonal fluctuation of raw materials: Shrimp and crab shell supply is affected by fishing seasons, policies, and market availability;

Marketing difficulties: Limited customer awareness (especially in agriculture and environmental industries) slows market penetration and demand release.

This report aims to provide a comprehensive presentation of the global market for Chitosan Derivatives, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Chitosan Derivatives by region & country, by Type, and by Application.

The Chitosan Derivatives market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chitosan Derivatives.

Market Segmentation

By Company

• Kitozyme
• Primex Iceland
• Vietnam Food
• Kunpoong Bio
• BIO21
• ChitoLytic
• Mirae Biotech
• Heppe Medical Chitosan
• Yaizu Suisankagaku
• Golden-Shell
• Lvshen Bioengineering
• AK Biotech
• Aoxin Biotechnology
• Jinhu Crust Product
• Qingdao Yunzhou Biochemistry

Segment by Type

• Chitosan HCl
• Carboxymethyl Chitosan
• Chitosan Quaternary Ammonium Salt
• Hydroxypropyl Chitosan
• Chitosan Oligosaccharide
• Others

Segment by Application

• Medical
• Health Food
• Cosmetics
• Agriculture
• Water Treatment
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Chitosan Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Chitosan Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Chitosan Derivatives in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Chitosan Derivatives Product Introduction
• 1.2 Global Chitosan Derivatives Market Size Forecast
  • 1.2.1 Global Chitosan Derivatives Sales Value (2020-2031)
  • 1.2.2 Global Chitosan Derivatives Sales Volume (2020-2031)
  • 1.2.3 Global Chitosan Derivatives Sales Price (2020-2031)
• 1.3 Chitosan Derivatives Market Trends & Drivers
  • 1.3.1 Chitosan Derivatives Industry Trends
  • 1.3.2 Chitosan Derivatives Market Drivers & Opportunity
  • 1.3.3 Chitosan Derivatives Market Challenges
  • 1.3.4 Chitosan Derivatives Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Chitosan Derivatives Players Revenue Ranking (2024)
• 2.2 Global Chitosan Derivatives Revenue by Company (2020-2025)
• 2.3 Global Chitosan Derivatives Players Sales Volume Ranking (2024)
• 2.4 Global Chitosan Derivatives Sales Volume by Company Players (2020-2025)
• 2.5 Global Chitosan Derivatives Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Chitosan Derivatives Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Chitosan Derivatives Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Chitosan Derivatives
• 2.9 Chitosan Derivatives Market Competitive Analysis
  • 2.9.1 Chitosan Derivatives Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Chitosan Derivatives Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chitosan Derivatives as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Chitosan HCl
  • 3.1.2 Carboxymethyl Chitosan
  • 3.1.3 Chitosan Quaternary Ammonium Salt
  • 3.1.4 Hydroxypropyl Chitosan
  • 3.1.5 Chitosan Oligosaccharide
  • 3.1.6 Others
• 3.2 Global Chitosan Derivatives Sales Value by Type
  • 3.2.1 Global Chitosan Derivatives Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Chitosan Derivatives Sales Value, by Type (2020-2031)
  • 3.2.3 Global Chitosan Derivatives Sales Value, by Type (%) (2020-2031)
• 3.3 Global Chitosan Derivatives Sales Volume by Type
  • 3.3.1 Global Chitosan Derivatives Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Chitosan Derivatives Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Chitosan Derivatives Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Chitosan Derivatives Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Medical
  • 4.1.2 Health Food
  • 4.1.3 Cosmetics
  • 4.1.4 Agriculture
  • 4.1.5 Water Treatment
  • 4.1.6 Others
• 4.2 Global Chitosan Derivatives Sales Value by Application
  • 4.2.1 Global Chitosan Derivatives Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Chitosan Derivatives Sales Value, by Application (2020-2031)
  • 4.2.3 Global Chitosan Derivatives Sales Value, by Application (%) (2020-2031)
• 4.3 Global Chitosan Derivatives Sales Volume by Application
  • 4.3.1 Global Chitosan Derivatives Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Chitosan Derivatives Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Chitosan Derivatives Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Chitosan Derivatives Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Chitosan Derivatives Sales Value by Region
  • 5.1.1 Global Chitosan Derivatives Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Chitosan Derivatives Sales Value by Region (2020-2025)
  • 5.1.3 Global Chitosan Derivatives Sales Value by Region (2026-2031)
  • 5.1.4 Global Chitosan Derivatives Sales Value by Region (%), (2020-2031)
• 5.2 Global Chitosan Derivatives Sales Volume by Region
  • 5.2.1 Global Chitosan Derivatives Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Chitosan Derivatives Sales Volume by Region (2020-2025)
  • 5.2.3 Global Chitosan Derivatives Sales Volume by Region (2026-2031)
  • 5.2.4 Global Chitosan Derivatives Sales Volume by Region (%), (2020-2031)
• 5.3 Global Chitosan Derivatives Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Chitosan Derivatives Sales Value, 2020-2031
  • 5.4.2 North America Chitosan Derivatives Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Chitosan Derivatives Sales Value, 2020-2031
  • 5.5.2 Europe Chitosan Derivatives Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Chitosan Derivatives Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Chitosan Derivatives Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Chitosan Derivatives Sales Value, 2020-2031
  • 5.7.2 South America Chitosan Derivatives Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Chitosan Derivatives Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Chitosan Derivatives Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Chitosan Derivatives Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Chitosan Derivatives Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Chitosan Derivatives Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Chitosan Derivatives Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Chitosan Derivatives Sales Value, 2020-2031
  • 6.3.2 United States Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Chitosan Derivatives Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Chitosan Derivatives Sales Value, 2020-2031
  • 6.4.2 Europe Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Chitosan Derivatives Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Chitosan Derivatives Sales Value, 2020-2031
  • 6.5.2 China Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Chitosan Derivatives Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Chitosan Derivatives Sales Value, 2020-2031
  • 6.6.2 Japan Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Chitosan Derivatives Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Chitosan Derivatives Sales Value, 2020-2031
  • 6.7.2 South Korea Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Chitosan Derivatives Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Chitosan Derivatives Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Chitosan Derivatives Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Chitosan Derivatives Sales Value, 2020-2031
  • 6.9.2 India Chitosan Derivatives Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Chitosan Derivatives Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Kitozyme
  • 7.1.1 Kitozyme Company Information
  • 7.1.2 Kitozyme Introduction and Business Overview
  • 7.1.3 Kitozyme Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Kitozyme Chitosan Derivatives Product Offerings
  • 7.1.5 Kitozyme Recent Development
• 7.2 Primex Iceland
  • 7.2.1 Primex Iceland Company Information
  • 7.2.2 Primex Iceland Introduction and Business Overview
  • 7.2.3 Primex Iceland Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Primex Iceland Chitosan Derivatives Product Offerings
  • 7.2.5 Primex Iceland Recent Development
• 7.3 Vietnam Food
  • 7.3.1 Vietnam Food Company Information
  • 7.3.2 Vietnam Food Introduction and Business Overview
  • 7.3.3 Vietnam Food Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Vietnam Food Chitosan Derivatives Product Offerings
  • 7.3.5 Vietnam Food Recent Development
• 7.4 Kunpoong Bio
  • 7.4.1 Kunpoong Bio Company Information
  • 7.4.2 Kunpoong Bio Introduction and Business Overview
  • 7.4.3 Kunpoong Bio Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Kunpoong Bio Chitosan Derivatives Product Offerings
  • 7.4.5 Kunpoong Bio Recent Development
• 7.5 BIO21
  • 7.5.1 BIO21 Company Information
  • 7.5.2 BIO21 Introduction and Business Overview
  • 7.5.3 BIO21 Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 BIO21 Chitosan Derivatives Product Offerings
  • 7.5.5 BIO21 Recent Development
• 7.6 ChitoLytic
  • 7.6.1 ChitoLytic Company Information
  • 7.6.2 ChitoLytic Introduction and Business Overview
  • 7.6.3 ChitoLytic Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 ChitoLytic Chitosan Derivatives Product Offerings
  • 7.6.5 ChitoLytic Recent Development
• 7.7 Mirae Biotech
  • 7.7.1 Mirae Biotech Company Information
  • 7.7.2 Mirae Biotech Introduction and Business Overview
  • 7.7.3 Mirae Biotech Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Mirae Biotech Chitosan Derivatives Product Offerings
  • 7.7.5 Mirae Biotech Recent Development
• 7.8 Heppe Medical Chitosan
  • 7.8.1 Heppe Medical Chitosan Company Information
  • 7.8.2 Heppe Medical Chitosan Introduction and Business Overview
  • 7.8.3 Heppe Medical Chitosan Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Heppe Medical Chitosan Chitosan Derivatives Product Offerings
  • 7.8.5 Heppe Medical Chitosan Recent Development
• 7.9 Yaizu Suisankagaku
  • 7.9.1 Yaizu Suisankagaku Company Information
  • 7.9.2 Yaizu Suisankagaku Introduction and Business Overview
  • 7.9.3 Yaizu Suisankagaku Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Yaizu Suisankagaku Chitosan Derivatives Product Offerings
  • 7.9.5 Yaizu Suisankagaku Recent Development
• 7.10 Golden-Shell
  • 7.10.1 Golden-Shell Company Information
  • 7.10.2 Golden-Shell Introduction and Business Overview
  • 7.10.3 Golden-Shell Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Golden-Shell Chitosan Derivatives Product Offerings
  • 7.10.5 Golden-Shell Recent Development
• 7.11 Lvshen Bioengineering
  • 7.11.1 Lvshen Bioengineering Company Information
  • 7.11.2 Lvshen Bioengineering Introduction and Business Overview
  • 7.11.3 Lvshen Bioengineering Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Lvshen Bioengineering Chitosan Derivatives Product Offerings
  • 7.11.5 Lvshen Bioengineering Recent Development
• 7.12 AK Biotech
  • 7.12.1 AK Biotech Company Information
  • 7.12.2 AK Biotech Introduction and Business Overview
  • 7.12.3 AK Biotech Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 AK Biotech Chitosan Derivatives Product Offerings
  • 7.12.5 AK Biotech Recent Development
• 7.13 Aoxin Biotechnology
  • 7.13.1 Aoxin Biotechnology Company Information
  • 7.13.2 Aoxin Biotechnology Introduction and Business Overview
  • 7.13.3 Aoxin Biotechnology Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.13.4 Aoxin Biotechnology Chitosan Derivatives Product Offerings
  • 7.13.5 Aoxin Biotechnology Recent Development
• 7.14 Jinhu Crust Product
  • 7.14.1 Jinhu Crust Product Company Information
  • 7.14.2 Jinhu Crust Product Introduction and Business Overview
  • 7.14.3 Jinhu Crust Product Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.14.4 Jinhu Crust Product Chitosan Derivatives Product Offerings
  • 7.14.5 Jinhu Crust Product Recent Development
• 7.15 Qingdao Yunzhou Biochemistry
  • 7.15.1 Qingdao Yunzhou Biochemistry Company Information
  • 7.15.2 Qingdao Yunzhou Biochemistry Introduction and Business Overview
  • 7.15.3 Qingdao Yunzhou Biochemistry Chitosan Derivatives Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.15.4 Qingdao Yunzhou Biochemistry Chitosan Derivatives Product Offerings
  • 7.15.5 Qingdao Yunzhou Biochemistry Recent Development

8 Industry Chain Analysis

• 8.1 Chitosan Derivatives Industrial Chain
• 8.2 Chitosan Derivatives Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Chitosan Derivatives Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Chitosan Derivatives Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer